BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 14678959)

  • 1. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors.
    Cullen KJ; Newkirk KA; Schumaker LM; Aldosari N; Rone JD; Haddad BR
    Cancer Res; 2003 Dec; 63(23):8097-102. PubMed ID: 14678959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.
    Shiga H; Heath EI; Rasmussen AA; Trock B; Johnston PG; Forastiere AA; Langmacher M; Baylor A; Lee M; Cullen KJ
    Clin Cancer Res; 1999 Dec; 5(12):4097-104. PubMed ID: 10632346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is glutathione-S-transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck?
    Vural E; Alexiou M; Hunt J; Korourian S; Hanna E
    Am J Otolaryngol; 2001; 22(4):257-60. PubMed ID: 11464322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression and amplification of glutathione S-transferase pi gene in head and neck squamous cell carcinomas.
    Wang X; Pavelic ZP; Li Y; Gleich L; Gartside PS; Pavelic L; Gluckman JL; Stambrook PJ
    Clin Cancer Res; 1997 Jan; 3(1):111-4. PubMed ID: 9815545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W; Liu G; Zheng J
    Eur J Pharmacol; 2007 Jul; 568(1-3):61-7. PubMed ID: 17509556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of glutathione S-transferase-Pi can predict chemotherapy response in patients with nonsmall cell lung carcinoma.
    Bai F; Nakanishi Y; Kawasaki M; Takayama K; Yatsunami J; Pei XH; Tsuruta N; Wakamatsu K; Hara N
    Cancer; 1996 Aug; 78(3):416-21. PubMed ID: 8697385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of glutathione transferase-pi in untreated primary non-small-cell lung cancer.
    Arai T; Yasuda Y; Takaya T; Hayakawa K; Toshima S; Shibuya C; Kashiki Y; Yoshimi N; Shibayama M
    Cancer Detect Prev; 2000; 24(3):252-7. PubMed ID: 10975287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase pi in squamous cell carcinoma of the head and neck.
    Bentz BG; Haines GK; Radosevich JA
    Laryngoscope; 2000 Oct; 110(10 Pt 1):1642-7. PubMed ID: 11037818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification.
    Singh B; Gogineni SK; Sacks PG; Shaha AR; Shah JP; Stoffel A; Rao PH
    Cancer Res; 2001 Jun; 61(11):4506-13. PubMed ID: 11389082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines.
    Bradford CR; Zhu S; Ogawa H; Ogawa T; Ubell M; Narayan A; Johnson G; Wolf GT; Fisher SG; Carey TE
    Head Neck; 2003 Aug; 25(8):654-61. PubMed ID: 12884349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer.
    Schneider S; Uchida K; Brabender J; Baldus SE; Yochim J; Danenberg KD; Salonga D; Chen P; Tsao-Wei D; Groshen S; Hoelscher AH; Schneider PM; Danenberg PV
    J Am Coll Surg; 2005 Mar; 200(3):336-44. PubMed ID: 15737843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer.
    Harpole DH; Moore MB; Herndon JE; Aloia T; D'Amico TA; Sporn T; Parr A; Linoila I; Allegra C
    Clin Cancer Res; 2001 Mar; 7(3):562-9. PubMed ID: 11297249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A; Alavi S; Olopade OI; Pauletti G; Aghamohammadi N; Aghamohammadi M; Gornbein JA; Calcaterra TC; Slamon DJ; Wang MB; Srivatsan ES
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glutathione-S-transferase expression in oral squamous cell carcinoma].
    Pannone G; Lo Muzio L; Pappalardo S; Bambini F; Rubini C; Fioroni M; Fanali S
    Minerva Stomatol; 2000 Mar; 49(3):107-17. PubMed ID: 20047209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCND1 amplification predicts sensitivity to chemotherapy and chemoradiotherapy in head and neck squamous cell carcinoma.
    Ishiguro R; Fujii M; Yamashita T; Tashiro M; Tomita T; Ogawa K; Kameyama K
    Anticancer Res; 2003; 23(6D):5213-20. PubMed ID: 14981992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione-S transferase-pi expression in non small cell lung cancer in the assessment of response to chemotherapy.
    Unsal M; Akpolat I; Kandemir B
    Saudi Med J; 2003 May; 24(5):493-8. PubMed ID: 12847624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
    Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
    Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide screening for radiation response factors in head and neck cancer.
    Singh B; Kim SH; Carew JF; Yu I; Shaha AR; Wolden S; Boyle J; Shah JP; Rao PH
    Laryngoscope; 2000 Aug; 110(8):1251-6. PubMed ID: 10942121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.